We are live on ! Find out more
NGNE icon

Neurogene
NGNE

60 hedge funds and large institutions have $617M invested in Neurogene in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 7

233% more capital invested

Capital invested by funds: $186M → $617M (+$432M)

71% more funds holding

Funds holding: 35 → 60 (+25)

19.71% more ownership

Funds ownership: 74.68% → 94.39% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

Holders
60
Holders Change
+25
Holders Change %
+71.43%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
32
Increased
10
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$27.7M
2
RI
RTW Investments
New York
+$25.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$15.3M
4
CC
Commodore Capital
New York
+$6.68M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.38M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$6.93M
2
Morgan Stanley
Morgan Stanley
New York
-$5.46M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$2.94M
4
Walleye Capital
Walleye Capital
New York
-$2.93M
5
CH
CVI Holdings
Delaware
-$2.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
26
Nantahala Capital Management
Connecticut
$3.68M – – –
Renaissance Technologies
27
Renaissance Technologies
New York
$2.99M +$284K +8,513 +17%
Jane Street
28
Jane Street
New York
$2.79M +$1.83M +54,888 New
DCM
29
Driehaus Capital Management
Illinois
$2.32M +$1.52M +45,654 New
State Street
30
State Street
Massachusetts
$1.59M +$1.04M +31,227 New
Marshall Wace
31
Marshall Wace
United Kingdom
$1.54M +$1.01M +30,218 New
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$1.43M +$936K +28,033 New
GTC
33
Ghost Tree Capital
New York
$1.27M +$835K +25,000 New
Northern Trust
34
Northern Trust
Illinois
$1.15M +$756K +22,635 New
Bank of America
35
Bank of America
North Carolina
$1.04M -$977K -29,255 -59%
Citigroup
36
Citigroup
New York
$892K +$585K +17,521 New
EI
37
EAM Investors
California
$616K +$404K +12,101 New
Barclays
38
Barclays
United Kingdom
$611K +$401K +12,000 New
MTIM
39
Marathon Trading Investment Management
Pennsylvania
$611K +$401K +12,000 New
CSS
40
Cubist Systematic Strategies
Connecticut
$546K +$358K +10,720 New
Stifel Financial
41
Stifel Financial
Missouri
$498K +$327K +9,784 New
UBS Group
42
UBS Group
Switzerland
$495K +$291K +8,718 +872%
BHCM
43
Brevan Howard Capital Management
Jersey
$410K +$269K +8,064 New
American Century Companies
44
American Century Companies
Missouri
$343K +$225K +6,747 New
ECM
45
ExodusPoint Capital Management
New York
$325K -$465K -13,924 -69%
SSA
46
Schonfeld Strategic Advisors
New York
$301K +$197K +5,905 New
PFMU
47
Privium Fund Management (UK)
United Kingdom
$274K +$196K +5,860 New
Charles Schwab
48
Charles Schwab
California
$267K +$175K +5,239 New
PAS
49
Point72 Asia (Singapore)
Singapore
$255K +$167K +5,004 New
Two Sigma Investments
50
Two Sigma Investments
New York
$202K +$132K +3,961 New
1
2
3

NGNE Hedge Fund Activity: Q1 2024 in Review

60 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2024, worth a combined $617M — up 233% from $186M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NGNE positions and 7 closed out — a net gain of 25 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $27.7M. The largest seller was Cormorant Asset Management, cutting an estimated $6.93M.

  • 60 institutional investors held Neurogene (NGNE) as of Q1 2024, up from 35 in Q4 2023.
  • Funds reported $617M of Neurogene stock for Q1 2024, up 233% quarter-over-quarter.
  • 32 funds opened new Neurogene positions in Q1 2024 and 7 closed out, a net change of +25 holders.
  • The largest Neurogene buyer in Q1 2024 was BlackRock, an estimated $27.7M added.
  • The largest Neurogene seller in Q1 2024 was Cormorant Asset Management, an estimated $6.93M sold.

Based on aggregated 13F filings for Q1 2024.